BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1962086)

  • 1. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus.
    Carpenter JL; Parks JM
    Rev Infect Dis; 1991; 13(5):789-96. PubMed ID: 1962086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
    Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE
    Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
    Levine B; Chaisson RE
    Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS.
    Shafer RW; Sierra MF
    Clin Infect Dis; 1992 Jul; 15(1):161-2. PubMed ID: 1617056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients.
    Rooney G; Nelson MR; Gazzard B
    J Clin Pathol; 1996 Oct; 49(10):821-3. PubMed ID: 8943748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium kansasii and human immunodeficiency virus co-infection in London.
    Klein JL; Corbett EL; Slade PM; Miller RF; Coker RJ
    J Infect; 1998 Nov; 37(3):252-9. PubMed ID: 9892529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical importance of Mycobacterium kansasii and evaluation of the need to identify nontuberculous mycobacteria].
    Etxebarrieta M; Rodrigo A; Martín C; Ojer M; Ruz A; Dorronsoro I
    Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):113-6. PubMed ID: 11904083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.
    Lillo M; Orengo S; Cernoch P; Harris RL
    Rev Infect Dis; 1990; 12(5):760-7. PubMed ID: 2237115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacteria other than tuberculosis. Pulmonary involvement in patients with acquired immunodeficiency syndrome.
    Tenholder MF; Moser RJ; Tellis CJ
    Arch Intern Med; 1988 Apr; 148(4):953-5. PubMed ID: 3355312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007-2012.
    Varley CD; Ku JH; Henkle E; Schafer SD; Winthrop KL
    Emerg Infect Dis; 2017 Mar; 23(3):533-535. PubMed ID: 28221103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
    Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
    Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease due to Mycobacterium kansasii in the Czech Republic: 1984-89.
    Kaustová J; Chmelík M; Ettlová D; Hudec V; Lazarová H; Richtrová S
    Tuber Lung Dis; 1995 Jun; 76(3):205-9. PubMed ID: 7548902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culture of Mycobacterium kansasii in the blood of an HIV negative patient.
    Veale D; Fishwick D; White JE; Gascoigne AD; Gould K; Corris PA
    Thorax; 1993 Jun; 48(6):672-3. PubMed ID: 8346502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium kansasii infection following primary pulmonary malignancy.
    Gettler JF; el-Sadr W
    Chest; 1994 Jan; 105(1):325-6. PubMed ID: 8275774
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe dEtude Des Mycobactéries de la Seine-Saint-Denis.
    Lortholary O; Deniel F; Boudon P; Le Pennec MP; Mathieu M; Soilleux M; Le Pendeven C; Loiseau P; Vincent V; Valeyre D
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):68-73. PubMed ID: 10094172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.
    El-Solh AA; Nopper J; Abdul-Khoudoud MR; Sherif SM; Aquilina AT; Grant BJ
    Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.
    Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL
    Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
    Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
    Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right middle lobe syndrome caused by Mycobacterium fortuitum in a patient with human immunodeficiency virus infection.
    Lambert GW; Baddour LM
    South Med J; 1992 Jul; 85(7):767-9. PubMed ID: 1631699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.